Literature DB >> 12021949

Neurological manifestations of the oculodentodigital dysplasia syndrome.

Tobias Loddenkemper1, Kerstin Grote, Stefan Evers, Michael Oelerich, Florian Stögbauer.   

Abstract

Oculodentodigital dysplasia (ODDD) (MIM 164200) is a rare autosomal dominant inherited disorder affecting the development of the face, eyes, limbs and dentition. Neurological complications are thought to be occasional manifestations of the disorder. This report illustrates the neurological manifestations by a pedigree of two ODDD patients with spastic paraparesis, cerebral white matter hyperintensity and basal ganglia hypointensity. A systematic review of the English, French, German and Italian literature on ODDD is also provided to summarize the neurological manifestations of the disorder. 243 previously described ODDD cases presented a spectrum of neurological manifestation including spasticity (25), subcortical white matter lesions (9) and basal ganglia changes (6) on MRI. Additional findings consisted of gaze palsy and squinting (28), bladder and bowel disturbances (21), visual loss (20) and blindness (4), hearing loss (15), ataxia (11), nystagmus (9), muscle weakness (5) and paresthesias (3). Neurological manifestations, including spasticity associated with MRI changes, are an underrecognized feature in the ODDD phenotype. A clinical guide to the neurological manifestations of ODDD may assist in the assessment of patients with this condition.

Entities:  

Mesh:

Year:  2002        PMID: 12021949     DOI: 10.1007/s004150200068

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  50 in total

1.  The TLR3 ligand polyI: C downregulates connexin 43 expression and function in astrocytes by a mechanism involving the NF-kappaB and PI3 kinase pathways.

Authors:  Yongmei Zhao; Mark A Rivieccio; Sarah Lutz; Eliana Scemes; Celia F Brosnan
Journal:  Glia       Date:  2006-12       Impact factor: 7.452

Review 2.  Life cycle of connexins in health and disease.

Authors:  Dale W Laird
Journal:  Biochem J       Date:  2006-03-15       Impact factor: 3.857

3.  Organizational principles of the connexin-related brain transcriptome.

Authors:  David C Spray; Dumitru A Iacobas
Journal:  J Membr Biol       Date:  2007-07-27       Impact factor: 1.843

Review 4.  Gap junctions couple astrocytes and oligodendrocytes.

Authors:  Jennifer L Orthmann-Murphy; Charles K Abrams; Steven S Scherer
Journal:  J Mol Neurosci       Date:  2008-05       Impact factor: 3.444

5.  Functional heterotypic interactions between astrocyte and oligodendrocyte connexins.

Authors:  Laura M Magnotti; Daniel A Goodenough; David L Paul
Journal:  Glia       Date:  2011-01       Impact factor: 7.452

Review 6.  Gap junctions in inherited human disease.

Authors:  Georg Zoidl; Rolf Dermietzel
Journal:  Pflugers Arch       Date:  2010-02-07       Impact factor: 3.657

7.  A dominant connexin43 mutant does not have dominant effects on gap junction coupling in astrocytes.

Authors:  Sameh Wasseff; Charles K Abrams; Steven S Scherer
Journal:  Neuron Glia Biol       Date:  2011-03-04

8.  A dominant loss-of-function GJA1 (Cx43) mutant impairs parturition in the mouse.

Authors:  Dan Tong; Xuerong Lu; Hong-Xing Wang; Isabelle Plante; Ed Lui; Dale W Laird; Donglin Bai; Gerald M Kidder
Journal:  Biol Reprod       Date:  2009-01-28       Impact factor: 4.285

9.  Ca2+ responses in enteric glia are mediated by connexin-43 hemichannels and modulate colonic transit in mice.

Authors:  Jonathon McClain; Vladimir Grubišić; David Fried; Roberto A Gomez-Suarez; Gina M Leinninger; Jean Sévigny; Vladimir Parpura; Brian D Gulbransen
Journal:  Gastroenterology       Date:  2013-11-06       Impact factor: 22.682

Review 10.  Variable expression of neurological phenotype in autosomal recessive oculodentodigital dysplasia of two sibs and review of the literature.

Authors:  Shelagh K Joss; Sam Ghazawy; Susan Tomkins; Mushtaq Ahmed; John Bradbury; Eamonn Sheridan
Journal:  Eur J Pediatr       Date:  2007-05-03       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.